Ashoka Refineries Limited Overview
Ashoka Refineries Limited is a Raipur-based, BSE-listed micro-cap. Its listed corporate shell long outlived its original operating purpose. The company began in 1991–1993 as a crude edible-oil refiner with a 7,500 MTA semi-continuous refinery in Raipur's Rawabhata Industrial Area. It now has no manufacturing activity and no fixed assets. It describes itself as primarily a trader of polymer granules (PP, HDPE, LDPE, LLDPE, PVC), rexine products and woven/FIBC bags, plus marketing and operational-assistance services.
After revenue of INR 2.31 crore in FY2022, turnover collapsed to INR 3.64 lakh in FY2026, and the company has posted two consecutive annual losses of about INR 15–17 lakh. Its value to holders lies chiefly in its clean listing, debt-light balance sheet (net worth about INR 2.45 crore) and the optionality of a future business injection by the promoter family (Mansoor Ahmed and his son, MD Hifzul Rahim). The same family also directs Natura Hue-Chem Limited and New Era Alkaloids & Exports Limited. Investors face thin liquidity, GSM surveillance and recurring auditor turnover.
Company's own description
Website: The company presents itself as principally a trader of plastic polymer granules (PP, HDPE, LDPE, LLDPE and PVC), rexine products, and PP/HDPE/FIBC bags. It adds that it carries out marketing and promotional activities and provides related operational assistance.
Annual report: The FY2026 MD&A (Annexure C) says the company is "mainly engaged in trading of goods" in a single segment, so no segment reporting is required.
No manufacturing: The Directors' Report states the company is not engaged in any manufacturing activity, which is why energy-conservation and technology-absorption disclosures are marked not applicable (AR FY26, Section 21).
Memorandum objects (legal scope)
According to Screener's summary of the annual reports and the original prospectus-era description (Sharekhan), the main objects are:
-
To import, export, buy, sell, manufacture, refine, prepare and deal in oil and oil substances, and to set up oil extraction and refining plants.
-
To undertake wholesale and retail business or indenting in oil products and other products.
-
Cargo handling and import/export trading. This object is why TradingView characterises the company as a "logistics / cargo handling" provider.
Independent characterisation
On the evidence of the FY2022–FY2026 financials, Ashoka Refineries is best described as a dormant listed shell with intermittent, small-ticket B2B commodity trading:
Revenue model: 100% product trading, with an asserted service component (marketing/operational assistance). There is no subscription, licensing or recurring-revenue element. Revenue is lumpy and appears to depend on a handful of back-to-back trades.
Value-chain position: Intermediary or stockist between polymer producers or larger distributors and downstream converters (bag and packaging makers). There is no inventory on the balance sheet (inventory days nil in every year FY2021–FY2026 per Screener), consistent with back-to-back or indent-based trading.
Customers: Not publicly disclosed. The product mix implies small and medium plastic processors and packaging converters in Chhattisgarh and central India.
End-markets: Packaging (woven sacks, FIBC bulk bags for cement, fertiliser, food grain and minerals), plastic processing, and rexine for upholstery and footwear.
Geography: India only. Foreign-exchange earnings and outgo were nil in FY2025 and FY2026 (AR FY25; AR FY26).
Classification conflicts in third-party data
| Source | Description given | Assessment |
|---|---|---|
| roic.ai (late 2025) | Manufacturer of industrial oils and lubricants with a branded "Ashoka" range (textile, hydraulic, rubber-process, heat-transfer oils, etc.) | Not corroborated by any company filing reviewed. The AR explicitly states no manufacturing activity. Likely an aggregator data-merge error with an unrelated lubricants business |
| TradingView | Logistics services / cargo handling | Reflects a memorandum object, not demonstrated activity |
| Simply Wall St | Trading of goods in India | Consistent with AR |
| Screener | Trading of goods | Consistent with AR |
| Company website | Polymer granules, rexine, PP/HDPE/FIBC bags trading | Primary source; adopted in this dossier |
Third-party descriptions are inconsistent, and investors should rely on the filings:
Strategy
Stated strategy (themes from AR FY26, paraphrased)
Recovery intent: The Board says it is pursuing "strategic measures" to drive growth and expects improvement in the current year, barring unforeseen developments. It describes its efforts as laying a foundation for long-term recovery (Directors' Report, Section 2).
Expansion of trading: Directors and KMP aim to take the trading business forward and expand it (MD&A).
Self-assessed SWOT (MD&A): Strength is "strong determination." Weakness is a low equity base limiting growth. Opportunity is multiple avenues for expansion in trading. Threat is small scale of operations affecting competitiveness.
Cost discipline: The MD waived his remuneration for FY2026 and for the time being thereafter, citing the company's financial position (AR FY26 Notice, Item 5).
Initiative register (last 24 months)
| Date | Initiative | Detail | Target / KPI disclosed | Source |
|---|---|---|---|---|
| FY2025–FY2026 | Remuneration waiver | MD forgoes salary (INR 96,000 in FY2025 to nil) | — | AR FY26 |
| 1 Oct 2025 | Board refresh | Two new independent directors; committees reconstituted | — | AR FY26 |
| 30 Sep 2025 | Secretarial audit continuity | 5-year appointment of G Soni & Associates | — | AR FY26 |
| 2 Sep 2026 | Auditor change | KCMG & Associates appointed (fee cap INR 60,000 p.a.) | — | AR FY26 |
| — | Transformation programs, new business launches, platform investments | None announced | — | — |
| — | ESG / sustainability commitments | — | — | Not applicable / not disclosed |
| — | Medium-term financial targets or guidance | None issued | — | — |
Assessment. No concrete plan, capital raise, business-transfer proposal or customer pipeline has been disclosed. The "strategic measures" language is near-identical in AR FY25 and AR FY26, suggesting boilerplate rather than an executable plan.
Products & Services
The company has no brands, platforms, proprietary products or published price lists. The catalog below is drawn solely from the company's own website statement. Specifications, launch years, pricing and named flagship SKUs are not publicly disclosed for every line.
Analyst note. FY2026 revenue of INR 3.64 lakh is consistent with a very small number of trades. The breadth of the stated product list should not be read as evidence of an active multi-line business.
Product Portfolio
| # | Product / service line | Description (independent) | Typical target customer | Specs / pricing disclosed? | Status |
|---|---|---|---|---|---|
| 1 | Polypropylene (PP) granules | Commodity thermoplastic resin used for raffia/woven sacks, injection moulding and film | Woven-sack and FIBC makers, moulders | — | Stated active line (website) |
| 2 | HDPE granules | High-density polyethylene resin for pipes, blow-moulded containers and raffia | Pipe and container moulders | — | Stated active line |
| 3 | LDPE granules | Low-density polyethylene for film and liners | Film converters | — | Stated active line |
| 4 | LLDPE granules | Linear low-density polyethylene for stretch/cling film and liners | Film converters | — | Stated active line |
| 5 | PVC granules/compound | Polyvinyl chloride for pipes, cable and profiles | Pipe and cable makers | — | Stated active line |
| 6 | Rexine products | Leather-cloth / PVC-coated fabric | Upholstery, automotive trim, footwear and bag fabricators | — | Stated active line |
| 7 | PP woven bags | Sacks for cement, fertiliser, grain | Cement, fertiliser, agri-commodity buyers | — | Stated active line |
| 8 | HDPE bags | HDPE woven/film bags | Bulk-packaging users | — | Stated active line |
| 9 | FIBC (jumbo/bulk) bags | Flexible intermediate bulk containers, typically 0.5–2 t capacity | Mining, cement, chemicals, food | — | Stated active line |
| 10 | Marketing & promotional services | Commission/support services to principals | Manufacturers seeking regional market access | — | Stated active line |
| 11 | Operational assistance | Related operational support to trade counterparties | As above | — | Stated active line |
| 12 | Edible-oil refining (legacy) | Semi-continuous refining of crude edible oil, 7,500 MTA (1993) | Edible-oil packers | Historic | Discontinued. No fixed assets now; AR states no manufacturing |
| 13 | Cargo handling / import-export (object clause) | Listed in objects | — | — | No evidence of activity |
“—” = not publicly disclosed.
Financial Narrative
All accounts are standalone (no subsidiaries) and prepared under Ind AS.
Income statement
Table 6.1a — Income statement, INR lakh. Sources: Sharekhan key fundamentals for FY22–FY23; AR FY25 and AR FY26 for FY24–FY26; Screener for other income and PBT where the AR is not available.
Notes on Table 6.1a:
-
FY22–FY23 other income, EBITDA, PBT and tax are Screener crore figures converted to lakh and rounded to the nearest lakh, so they are approximate.
-
FY22–FY23 OCI is not disclosed in sources retrieved and is shown as 0.
-
FY24 expense figure is per AR FY25 (Sharekhan shows 149.90).
Table 6.1b — Per-share data, INR. Shares outstanding are 34,01,900 in every year.
There are no potentially dilutive instruments, so basic and diluted EPS are equal. Small EPS differences are rounding. Book value per share is computed from Screener net worth.
Table 6.1c — Margins, %. Computed from Table 6.1a.
Gross margin is shown as 0 because cost of goods sold (purchase of stock-in-trade) is not publicly disclosed in the sources retrieved. Screener holds this line behind a paywall. Treat the gross-margin row as not publicly disclosed, not as a true zero. AR FY26 reports the net and operating profit ratio as -426.55% (FY26) and -53.22% (FY25).
Revenue CAGR
Commentary. The P&L shows a business in near-terminal decline at the operating level.
FY2021–FY2022 restart: Revenue recovered from nil (FY2016–FY2020) to INR 2.31 crore with a 6.9% operating margin, consistent with a promoter injecting trading flows into the shell.
FY2023–FY2025 decline: Each year saw a step-down. The inflection came in FY2025, when revenue fell 79% and the cost base (about INR 48 lakh including purchases) could no longer be covered.
FY2026: Revenue of INR 3.64 lakh against expenses of INR 19.14 lakh shows a fixed overhead of about INR 15–16 lakh per year. That overhead is listing, audit, secretarial and RTA fees plus about INR 10 lakh of staff costs (Annexure D shows salaries of INR 4.60 lakh for the CS and INR 2.43 lakh each for two employees, among others).
No interest or depreciation: The company has no fixed assets and negligible debt, so EBITDA, EBIT and PBT are essentially identical.
Balance sheet
Table 6.2a — Balance sheet, INR crore (Screener).
Data conflicts and gaps:
Total assets: Sharekhan reports INR 2.5666 Cr (FY22), 2.8810 (FY23), 2.8791 (FY24), 2.7323 (FY25) and 2.6004 (FY26). The gap from Screener is likely due to presentation and classification (for example, OCI reserve treatment or netting). Both are shown; filings should be treated as definitive.
- Short-term vs. long-term split of the INR 0.15 crore borrowing. Not publicly disclosed. The amount has been unchanged since at least FY2015, which suggests a legacy unsecured loan.
Cash & equivalents: Not separately disclosed in sources retrieved. Zerodha reports net debt of INR 0.03 crore at March 2026, which implies cash of about INR 0.12 crore (a derived figure, flagged).
Working capital: AR FY26 current ratio is 3.15 (FY25: 11.97). The fall reflects a decrease in current assets, possibly reclassification of loans/advances to non-current. Absolute working capital is not publicly disclosed.
Commentary. The balance sheet is the company's main asset.
Equity: Paid-up capital of INR 3.40 crore is partly offset by accumulated losses (reserves of -INR 0.95 crore), leaving net worth of INR 2.45 crore.
FY2024 asset rotation: Investments fell from INR 1.92 crore to INR 0.38 crore, and the cash-flow statement shows INR 1.30 crore of investing inflow. At the same time, other assets rose by about INR 0.9 crore and CFO was -INR 1.53 crore. The proceeds of investment sales were therefore redeployed into receivables, loans or advances.
Quality of other assets is the key diligence point: The composition of the INR 2.22 crore of "other assets" (trade receivables, loans to parties, advances) is not detailed in the sources retrieved. Screener reports debtor days of 365 in FY2026, meaning receivables exceed a full year's sales.
Cash flow
Table 6.3a — Cash flow, INR crore (Screener).
Sharekhan's CFO figures match Screener: -0.3131, -0.0041, -1.5326, 0.2572, -0.1718.
Commentary.
- Free cash flow equals CFO because there is no capex.
FY2025 positive CFO: (+INR 0.26 crore) despite a net loss reflects receivable collection.
FY2026 CFO: (-INR 0.17 crore) roughly equals the net loss. This is the realistic annual cash burn of the listed shell at current activity.
Runway: At about INR 15–17 lakh of burn per year against net worth of about INR 2.45 crore, the book runway is long. The cash runway, however, depends on how quickly the other assets can be realised.
Ratios
Table 6.4a — Key ratios. Sources: AR FY26 ratio table for FY25–FY26; Screener and Sharekhan for earlier years; computed where noted.
Notes on Table 6.4a:
-
Zeros for FY22–FY24 in the current ratio, average-assets and receivable-turnover rows mean not publicly disclosed in the sources retrieved. They are zero-filled only so the table can be charted.
-
ROE for FY22–FY24 is from Sharekhan. AR FY26 gives FY25–FY26. Sharekhan shows FY25 at -6.91 and FY26 at -6.42; Screener shows FY26 at -6.36. Small discrepancies reflect averaging methods.
-
ROCE for FY22–FY24 is from Screener. AR FY26 gives FY25–FY26; Screener shows -6.06 and -6.00 for those years.
-
Debt/equity for FY22–FY24 is computed (0.15 / net worth).
-
Screener's FY2025 debtor days of 0 conflicts with AR FY25 receivable turnover of 1.00x, which implies significant receivables. Treat FY2025 debtor days as unreliable.
Ratios not meaningful or not disclosed:
ROIC: not disclosed; approximated by ROCE.
Net debt / EBITDA: not meaningful (EBITDA negative; net debt about INR 0.03 crore).
Interest coverage: not meaningful (finance cost about nil; AR marks it NA).
Inventory days: nil (no inventory).
Overall trend. Returns moved from mid-single-digit positive (FY2022) to about -6% (FY2025–FY2026), purely from revenue collapse against a fixed overhead. Leverage is negligible. Efficiency metrics such as asset turnover of 0.01x confirm the asset base is not being put to commercial use.
Recent quarterly trend
Table 6.5 — Quarterly results, INR crore (Screener).
The revenue break occurred in Q2 FY2025 (Sep 2024 quarter). Since then the company has posted a steady loss of about INR 4–5 lakh per quarter. Q1 FY2027 (June 2026 quarter, results of 13 Aug 2026) shows no change: sales of about INR 1 lakh and a net loss of about INR 4 lakh. TTM sales are INR 0.05 crore and TTM EPS is -INR 0.48 (Screener).
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Revenue by Segment and Segment Margins & Growth (%)
| Segment | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Trading of goods – revenue (INR Lakh) | 148.20 | 31.34 | 3.64 |
Trading of goods – pre-tax profit (INR Lakh) | 2.26 | -16.68 | -15.50 |
Trading of goods – PBT margin (%) | 1.5 | -53.2 | -425.8 |
Trading of goods – YoY revenue growth (%) | -22.2 | -78.9 | -88.4 |
Trading of goods – share of total revenue (%) | 100 | 100 | 100 |
Income Statement
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue from operations (INR Lakh) | 231.35 | 190.59 | 148.20 | 31.34 | 3.64 |
Other income (INR Lakh) | 3.00 | 4.00 | 3.97 | 0.00 | 0.00 |
Total expenses (INR Lakh) | 215.71 | 183.13 | 149.91 | 48.02 | 19.14 |
EBITDA = operating profit (INR Lakh) | 16.00 | 7.00 | -2.00 | -17.00 | -16.00 |
Depreciation (INR Lakh) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Finance cost (INR Lakh) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Profit before tax (INR Lakh) | 19.00 | 11.00 | 2.26 | -16.68 | -15.50 |
Tax expense (INR Lakh) | 0.00 | 2.00 | 0.57 | 0.00 | 0.00 |
Net profit (INR Lakh) | 18.38 | 8.86 | 1.69 | -16.68 | -15.50 |
Other comprehensive income (INR Lakh) | 0.00 | 0.00 | -1.88 | 2.00 | 2.32 |
Total comprehensive income (INR Lakh) | 18.38 | 8.86 | -0.19 | -14.68 | -13.18 |
Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
EPS basic = diluted, computed (INR) | 0.54 | 0.26 | 0.05 | -0.49 | -0.46 |
EPS as shown by Screener (INR) | 0.53 | 0.26 | 0.06 | -0.50 | -0.47 |
Dividend per share (INR) | 0 | 0 | 0 | 0 | 0 |
Book value per share (INR) | 7.08 | 8.03 | 8.03 | 7.58 | 7.20 |
Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Gross margin (%) | 0 | 0 | 0 | 0 | 0 |
EBITDA / operating margin (%) | 6.9 | 3.7 | -1.4 | -54.8 | -426.6 |
PBT margin (%) | 8.2 | 5.8 | 1.5 | -53.2 | -425.8 |
Net margin (%) | 7.9 | 4.6 | 1.1 | -53.2 | -425.8 |
CAGR by Period
| Period | CAGR |
|---|---|
FY2022 → FY2026 (4 years) | about -64.6% (computed) |
5-year (FY2021 → FY2026) | -44% (Screener) |
3-year | -72% (Screener) |
Balance Sheet
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Equity share capital (INR Cr) | 3.40 | 3.40 | 3.40 | 3.40 | 3.40 |
Reserves & surplus (INR Cr) | -0.99 | -0.67 | -0.67 | -0.82 | -0.95 |
Shareholders' equity / net worth (INR Cr) | 2.41 | 2.73 | 2.73 | 2.58 | 2.45 |
Borrowings – total (INR Cr) | 0.15 | 0.15 | 0.15 | 0.15 | 0.15 |
Other liabilities (INR Cr) | 0.26 | 0.65 | 0.03 | 0.02 | 0.05 |
Total liabilities & equity (INR Cr) | 2.82 | 3.53 | 2.91 | 2.75 | 2.65 |
Fixed assets incl. CWIP (INR Cr) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Goodwill & intangibles (INR Cr) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments (INR Cr) | 1.42 | 1.92 | 0.38 | 0.40 | 0.43 |
Other assets incl. receivables, loans, cash (INR Cr) | 1.40 | 1.61 | 2.53 | 2.35 | 2.22 |
Total assets (INR Cr) | 2.82 | 3.53 | 2.91 | 2.75 | 2.65 |
Cash Flow
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Cash from operating activities (INR Cr) | -0.31 | 0.00 | -1.53 | 0.26 | -0.17 |
Capital expenditure (INR Cr) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Free cash flow (INR Cr) | -0.31 | 0.00 | -1.53 | 0.26 | -0.17 |
Cash from investing activities (INR Cr) | 0.29 | 0.16 | 1.30 | 0.00 | 0.00 |
Cash from financing activities (INR Cr) | 0.03 | 0.03 | 0.04 | 0.00 | 0.00 |
Dividends paid (INR Cr) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share buybacks (INR Cr) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net change in cash (INR Cr) | 0.00 | 0.19 | -0.19 | 0.26 | -0.17 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
ROE (%) | 7.62 | 3.67 | 0.70 | -6.28 | -6.16 |
ROCE (%) | 8.14 | 4.04 | 0.69 | -6.10 | -5.95 |
ROA, computed on Screener year-end assets (%) | 6.5 | 2.5 | 0.6 | -6.1 | -5.8 |
Return on average total assets (%) | 0 | 0 | 0 | -5.89 | -5.73 |
Current ratio (x) | 0 | 0 | 0 | 11.97 | 3.15 |
Debt / equity (x) | 0.06 | 0.05 | 0.05 | 0.06 | 0.06 |
Asset turnover, computed (x) | 0.82 | 0.54 | 0.51 | 0.11 | 0.01 |
Trade receivable turnover (x) | 0 | 0 | 0 | 1.00 | 1.69 |
Debtor days (Screener) | 109 | 204 | 155 | 0 | 365 |
Cash conversion cycle (days, Screener) | 109 | 204 | 155 | 0 | 365 |
Income Statement and Per-Share Data
| Metric | Q1FY24 | Q2FY24 | Q3FY24 | Q4FY24 | Q1FY25 | Q2FY25 | Q3FY25 | Q4FY25 | Q1FY26 | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales (INR Cr) | 0.47 | 0.29 | 0.28 | 0.45 | 0.27 | 0.03 | 0.02 | 0.00 | 0.00 | 0.00 | 0.03 | 0.01 | 0.01 |
Expenses (INR Cr) | 0.47 | 0.31 | 0.30 | 0.43 | 0.29 | 0.07 | 0.07 | 0.05 | 0.04 | 0.04 | 0.07 | 0.05 | 0.05 |
Net profit (INR Cr) | 0.00 | -0.01 | 0.01 | 0.02 | -0.02 | -0.04 | -0.05 | -0.05 | -0.04 | -0.04 | -0.04 | -0.04 | -0.04 |
EPS (INR) | 0.00 | -0.03 | 0.03 | 0.06 | -0.06 | -0.12 | -0.15 | -0.15 | -0.12 | -0.12 | -0.12 | -0.12 | -0.12 |
Revenue by Region and Region Margins & Growth (%)
| Region | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
India – revenue (INR Lakh) | 148.20 | 31.34 | 3.64 |
Outside India – revenue (INR Lakh) | 0 | 0 | 0 |
India – YoY growth (%) | -22.2 | -78.9 | -88.4 |
India – share of revenue (%) | 100 | 100 | 100 |
Valuation Snapshot
| Metric | Value | Source / date |
|---|---|---|
Last available close | INR 15.43 | 5 Oct 2026 (Sharekhan; Trendlyne). Screener shows INR 15.4 |
52-week high / low | INR 16.24 / INR 11.79 | Sharekhan, Oct 2026. Screener: 16.2 / 11.8 |
Market capitalisation | INR 5.25 crore | Screener; Sharekhan |
Typical daily volume | 500–3,200 shares; often no trades for days | Emkay (22 Jun 2026: traded value INR 500); Trendlyne (5 Oct 2026: 1,400 shares) |
Beta (1Y) | -0.24 | TradingView |
Surveillance | GSM | Trendlyne |
Share Price & Returns
| Horizon | Return | Source |
|---|---|---|
1-year | +10% | Screener, Oct 2026 |
3-year CAGR | +39% | Screener, Oct 2026 |
5-year CAGR | +27% | Screener, Oct 2026 |
Since IPO (as of May 2025) | -70.1% | Simply Wall St, 6 May 2025 |
Share Price
| Metric | FY2024 | FY2025 | FY2026 | FY2027 YTD |
|---|---|---|---|---|
Share price (INR) | 0 | 11.95† | 12.15† | 15.43 |
Valuation Multiples
| Multiple | Ashoka Refineries | Basis | Peer comparison |
|---|---|---|---|
P/E (TTM) | -33.5x (not meaningful; loss-making) | TTM EPS -0.46 to -0.48 | Sundrop Brands 82.7x; IEL 47.3x; Integrated Proteins 406.7x (Sharekhan) |
P/B | 2.15–2.18x | Book value INR 7.09–7.20 | — |
EV / Sales | About 106x | EV about INR 5.28 Cr (mcap 5.25 + debt 0.15 − derived cash about 0.12) / TTM sales INR 0.05 Cr | — |
EV / EBITDA | Not meaningful (negative EBITDA) | — | Sundrop 58.2x; IEL 201.2x; Integrated Proteins 5.4x |
Market cap / net worth | About 2.1x | 5.25 / 2.45 | — |
Capital Markets
| Item | Status | Source |
|---|---|---|
Analyst coverage / consensus | None; covered by 0 analysts | Simply Wall St |
Dividend history | No dividends in the years shown by Screener (FY2015–FY2026); dividend yield 0% | Screener; Sharekhan dividend table (empty) |
Dividend policy | No dividend recommended given losses; resources conserved | AR FY26 Section 4 |
Buyback authorisations | None; no provision for purchase of own shares | AR FY26 Section 16 |
Credit ratings (Moody's / S&P / Fitch / domestic) | Not rated | No rating disclosed |
Debt maturity profile | INR 0.15 Cr borrowing outstanding since at least FY2015; terms and maturity not publicly disclosed | Screener |
Margin Analysis (%) — Promoter holding
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Promoter holding (%) | 33.83 | 33.00 | 32.94 | 32.94 | 32.94 |
DII holding (%) | 0.29 | 0.29 | 0.29 | 0.29 | 0.29 |
Public holding (%) | 65.87 | 66.71 | 66.77 | 66.76 | 66.76 |
Number of shareholders | 983 | 1,016 | 1,010 | 1,034 | 1,009 |
Analyst Conclusions
Management guidance
There is no quantitative guidance. Management expresses optimism that performance will improve in the current year, barring unforeseen developments, but offers no targets, volumes or timelines (AR FY26 Section 2 and MD&A). The Q1 FY2027 results (sales INR 0.01 crore, loss INR 0.04 crore) show no improvement so far.
Consensus
There is no sell-side coverage, and consensus growth expectations are not available.
Bull case (grounded in data)
-
Clean shell with option value. Net worth of INR 2.45 crore, D/E of 0.06x, no litigation, no IBC proceedings and an unmodified audit opinion make the company a usable vehicle for a business injection. The promoter family already runs two other listed companies.
-
Low burn relative to equity. The annual loss of about INR 15–17 lakh is about 6–7% of net worth. The MD's salary waiver and the low new audit fee (at most INR 60,000) keep the burn contained, so the shell can survive many years without dilution.
-
Asset realisation. If the INR 2.22 crore of other assets and INR 0.43 crore of investments are recoverable at book, realisable value (about INR 2.6 crore) is about half the market cap. This gives some floor, assuming asset quality holds.
Bear case (grounded in data)
-
No business. Revenue is down 98% from FY2022 to FY2026, and losses have been steady at about INR 4 lakh per quarter for eight quarters. There is no disclosed plan, customer or capital to restart trading.
-
Governance and asset-quality red flags:
-
Mid-term auditor resignation (Sep 2026), the third auditor change in nine years.
-
Edit-log disablement noted by the auditor.
-
365 debtor days.
-
Repeated drafting errors in statutory disclosures. Together these raise the probability that book value overstates realisable value.
-
-
Market-structure risk. GSM surveillance, daily volumes in the low thousands of rupees, about 2.2x P/B for a loss-making company, and about 106x EV/Sales imply heavy downside if speculative interest fades. Exit may be impossible at quoted prices.
Catalysts and monitorables (next 12 months)
| # | Monitorable | Expected timing | Why it matters |
|---|---|---|---|
| 1 | Reg. 30 auditor-resignation letter (reason stated by Batra Deepak) | Already filed 2 Sep 2026; review | Determines whether resignation reflects disagreement or information access issues |
| 2 | Q2 FY2027 results | By mid-Nov 2026 | Any revenue revival |
| 3 | First KCMG-audited quarter / limited review | Q2–Q3 FY2027 | Fresh audit view of receivables and advances |
| 4 | Composition of the INR 2.22 Cr other assets (receivables, loans, related parties) | FY2027 AR (Aug–Sep 2027) | Asset-quality test |
| 5 | Board resolutions on preferential issue, business transfer, merger or name/object change | Ad hoc | Shell-activation signal |
| 6 | Promoter holding changes / SAST disclosures | Quarterly (Jan, Apr, Jul 2027) | Change-of-control or creeping acquisition |
| 7 | GSM stage changes / trade-for-trade | Ad hoc | Liquidity |
| 8 | Q3 FY2027 results | By mid-Feb 2027 | Run-rate of losses |
| 9 | FY2027 audited results | By end-May 2027 | Equity erosion and going-concern commentary |
| 10 | Shareholder count trend (991 at Sep 2026) | Quarterly | Retail interest |
Analyst verdict
Ashoka Refineries Limited is not an operating company in any economically meaningful sense. It is a 35-year-old listed corporate vehicle whose original edible-oil refinery has disappeared from its balance sheet. Its trading activity peaked at INR 2.31 crore in FY2022 and has since fallen to INR 3.64 lakh, below the cost of keeping its listing alive.
The company is not in financial distress in the conventional sense. Debt is a negligible INR 0.15 crore, there is no litigation, the audit opinion is unmodified, and net worth of about INR 2.45 crore covers roughly a decade of current losses. That resilience, however, is static. Every year of inactivity erodes book value by about 6%, and nothing in the filings indicates a plan to reverse that.
The investment question therefore reduces to option value on a corporate action by the Mansoor Ahmed–Hifzul Rahim family, who also direct Natura Hue-Chem and New Era Alkaloids & Exports. At about 2.2x book and about 106x trailing sales, the market already prices a meaningful probability of such an event. No such event has been announced or rumoured in verifiable sources.
Against that option sit governance signals that institutional diligence cannot ignore:
-
A statutory auditor resigned mid-term in September 2026, with a same-day identical change at a sister company.
-
The auditor recorded that accounting-software audit trails were disabled and later re-enabled.
-
Receivables or advances make up the bulk of assets, with debtor days at a full year.
-
The annual report contains internal inconsistencies, including mismatched OCI signs, stale dates and mis-numbered agenda references.
-
Trading is under GSM surveillance with negligible liquidity.
Verdict: Uninvestable for institutional mandates. For speculative capital, it is an event-driven, binary option on a promoter-led restructuring, with asset-quality and liquidity risk that could exceed the apparent book-value floor. The single most important near-term diligence items are the auditor's resignation letter and a line-by-line review of the INR 2.22 crore of "other assets" in the FY2026 notes. Absent a disclosed business plan or capital injection, the base case is continued slow equity erosion at about INR 15 lakh per year.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | DIN | Tenure / appointment | Education | Age | Other listed directorships | Source |
|---|---|---|---|---|---|---|---|
Hifzul Rahim | Managing Director (KMP); Executive | 08,491,854 | Additional Director 10 Aug 2023; MD 1 Oct 2023–30 Sep 2026; re-appointed 1 Oct 2026–30 Sep 2029 | B.Com | 31 | Natura Hue-Chem Ltd (Director); New Era Alkaloids & Exports Ltd (Director) | AR FY26 Annexure A |
Mansoor Ahmed | Director (Executive); Promoter; Chair of Finance & Investment Committee | 01,398,796 | About 7 years per Simply Wall St (so around 2019); re-appointed by rotation 30 Sep 2025 | — | — | — | AR FY26; Simply Wall St |
Tulsi Ram Sahu | Director & Chief Financial Officer (KMP); Executive | 01,395,347 | Regularised 25 Oct 2018; re-appointed by rotation 30 Sep 2024 and 30 Sep 2026 | B.Com | 43 | — | AR FY26 Annexure A |
Aditya Sharma | Independent Director | 08,718,848 | Regularised 24 Sep 2021; 2nd term 13 Aug 2026–12 Aug 2031 | B.E. (Mechanical) | 34 | Natura Hue-Chem Ltd (ID); New Era Alkaloids & Exports Ltd (ID) | AR FY26 Annexure A |
Gaurav Soni | Independent Director; Chair of Audit Committee and Stakeholders Relationship Committee | 11,252,209 | From 1 Oct 2025 | — | — | — | AR FY26 |
Anchal Agrawal | Independent Director (woman); Chair of NRC | 11,257,393 | From 1 Oct 2025 | — | — | — | AR FY26 |
Garima Mogha | Company Secretary & Compliance Officer (KMP) | — (ACS 66541) | Since 2 Nov 2023 | B.Com; CS | 32 | — | AR FY26 Annexure D |
“—” = not publicly disclosed.
Board of Directors — Ravi Kamra
| Name | Role | Exit | Context | Source |
|---|---|---|---|---|
Ravi Kamra (DIN 00745058) | Independent Director; former Audit, NRC and SRC Chair | 30 Sep 2025 | Completed second consecutive term (board tenure about 17 years per Simply Wall St) | AR FY26 |
Satyawati Parashar (DIN 00761009) | Woman Independent Director | 30 Sep 2025 | Completed second consecutive term | AR FY26 |
Surendra Singh Sandhu | Executive Director | 20 Nov 2023 | Resigned | Motilal Oswal BSE feed |
Sudhir Dixit (DIN 02023125) | Director (retired by rotation, 2017 AGM agenda) | Exit date not publicly disclosed | Historical | 26th Annual Report |
Ruppal Padhiar | Company Secretary (2021) | Exit date not publicly disclosed | Predecessor CS | AR FY21 notice |
Board of Directors (Annual)
| Name | Designation | FY2025 remuneration (INR) | FY2026 remuneration (INR) | Change |
|---|---|---|---|---|
Hifzul Rahim | Managing Director | 96,000 | 0 | Waived (MD) |
Tulsi Ram Sahu | Director & CFO | 0 | 0 | Draws none |
Mansoor Ahmed | Executive Director | 0 | 0 | Draws none |
Garima Mogha | Company Secretary | 380,000 | 460,000 | +21.05% (pay-scale correction) |
Aditya Sharma | ID – sitting fees | 7,000 | 7,000 | Flat |
Ravi Kamra | ID – sitting fees | 7,000 | 4,000 | Part year |
Satyawati Parashar | ID – sitting fees | 7,000 | 4,000 | Part year |
Gaurav Soni | ID – sitting fees | 0 | 3,000 | New |
Anchal Agrawal | ID – sitting fees | 0 | 3,000 | New |
Lilesh Kumar Sahu | Employee | 207,000 | 69,000 | Part year |
Maradana Venkata Ramana | Employee (MBA Marketing) | 243,000 | 243,000 | Flat |
Chandra Kumar Dadagala | Employee | 243,000 | 243,000 | Flat |
Directors' Remuneration
| Committee | Chair | Members | FY2026 meetings |
|---|---|---|---|
Audit | Gaurav Soni (ID) | Tulsi Ram Sahu (ED/CFO), Anchal Agrawal (ID) | 4 |
Nomination & Remuneration | Anchal Agrawal (ID) | Aditya Sharma (ID), Gaurav Soni (ID) | 1 |
Stakeholders Relationship | Gaurav Soni (ID) | Tulsi Ram Sahu, Hifzul Rahim | 2 |
Finance & Investment | Mansoor Ahmed (ED, promoter) | Gaurav Soni (ID), Tulsi Ram Sahu | — |
“—” = not publicly disclosed.
Governance Detail
| Category | Dec-2024 | Mar-2025 | Sep-2025 | Mar-2026 | Sep-2026 |
|---|---|---|---|---|---|
Promoters (%) | 32.94 | 32.94 | 32.94 | 32.94 | 32.94 |
FIIs (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
DIIs (%) | 0.29 | 0.29 | 0.29 | 0.29 | 0.29 |
Public (%) | 66.76 | 66.76 | 66.76 | 66.76 | 66.77 |
Number of shareholders | 1,035 | 1,034 | 1,021 | 1,009 | 991 |
Major Shareholders
| Holder | Shares | % |
|---|---|---|
Reeta Atlani | 141,000 | 4.14 |
Sana Atlani | 124,900 | 3.67 |
Rajesh Atlani | 110,000 | 3.23 |
Kishor Atlani | 109,500 | 3.22 |
Mahesh Kodwani | 61,300 | 1.80 |
Himmatlal Sahu | 59,200 | 1.74 |
Ajay Chaudhary | 33,000 | 0.97 |
Avdhesh Jain | 32,900 | 0.97 |
Umesh Sahu | 32,800 | 0.96 |
Vishwajeet Thakur | 32,000 | 0.94 |
Competitive Landscape
Key Competitors
| # | Company | Segment overlap | Relative positioning vs. Ashoka Refineries | Source of peer link |
|---|---|---|---|---|
| 1 | Reliance Industries Ltd (polymers) | Largest Indian PP/PE/PVC producer; sells through its own distributor network | Upstream supplier-competitor; orders of magnitude larger | Independent (industry structure) |
| 2 | GAIL (India) Ltd | PE producer (Pata) | Upstream supplier-competitor | Independent |
| 3 | Indian Oil Corporation Ltd | PP/PE producer (Panipat, Paradip) | Upstream supplier-competitor | Independent |
| 4 | Haldia Petrochemicals Ltd (unlisted) | PE/PP producer | Upstream supplier-competitor | Independent |
| 5 | Emmbi Industries Ltd | FIBC and woven polymer products manufacturer | Direct product competitor in bags | Independent |
| 6 | Rishi Techtex Ltd | Woven sacks and FIBC manufacturer | Direct product competitor in bags | Independent |
| 7 | Commercial Syn Bags Ltd | FIBC manufacturer (central India) | Direct regional product competitor | Independent |
| 8 | Kanpur Plastipack Ltd | FIBC and woven sacks manufacturer | Direct product competitor | Independent |
| 9 | Trio Mercantile & Trading Ltd | Micro-cap trading company | Listed shell-trader peer | Business Standard peer list ("Trio Merc.") |
| 10 | Integrated Proteins Ltd | Micro-cap, edible-oil/agri classification | Classification peer | Sharekhan peer list |
| 11 | IEL Ltd | Micro-cap, edible-oil classification | Classification peer | Sharekhan peer list |
| 12 | Pioneer Agro Extracts Ltd | Micro-cap, edible-oil classification | Classification peer | Sharekhan peer list |
| 13 | Sundrop Brands Ltd | Branded edible oils/foods | Legacy-industry peer; much larger | Sharekhan peer list |
Peer Comparison FY2026
| Metric | Ashoka Refineries | Sundrop Brands | Integrated Proteins | IEL Ltd |
|---|---|---|---|---|
Share price (INR) | 15.43 | 611.05 | 12.20 | 5.20 |
P/E (x) | -33.54 | 82.70 | 406.67 | 47.27 |
EV/EBITDA (x) | Not meaningful (negative) | 58.17 | 5.43 | 201.20 |
ROE (%) | -6.16 | 53.40 | 1.20 | 1.38 |
Revenue FY2026 | INR 3.64 lakh | — | — | — |
Revenue growth FY2026 (%) | -88.4 | — | — | — |
Net margin FY2026 (%) | -425.8 | — | — | — |
R&D intensity (%) | 0 | — | — | — |
Recent Developments
There were no layoffs, contract wins, product launches, litigation or regulatory actions in the period.



